Meanwhile, the relationship between the expression of GPR137C and PRAD tumor cell stem was explored based on three items, i.e., differentially methylated probes-based (DMPss), DNA methylation-based (DNAss), and enhancer elements/DNA methylation-based (ENHss). Here, GPR137C is linked to prostate adenocarcinoma.